SBOT - Stellar Biotechnologies, Inc.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue9/30/20179/30/20169/30/20159/30/2014
Total Revenue228.2871,271.689758.689633.432
Cost of Revenue534.4531,127.828840.247404.388
Gross Profit-306.166143.861-81.558229.044
Operating Expenses
Research Development1,735.41,494.445837.4891,959.36
Selling General and Administrative3,182.983,557.7723,419.5453,697.56
Non Recurring----
Others----
Total Operating Expenses5,452.8336,180.0455,097.2816,061.308
Operating Income or Loss-5,224.546-4,908.356-4,338.592-5,427.876
Income from Continuing Operations
Total Other Income/Expenses Net194.698-110.5241,532.36319,008.324
Earnings Before Interest and Taxes-5,224.546-4,908.356-4,338.592-5,427.876
Interest Expense----
Income Before Tax-5,029.848-5,018.88-2,806.22913,580.448
Income Tax Expense0.87.236.845.6
Minority Interest----
Net Income From Continuing Ops-5,030.648-5,026.08-2,843.02913,534.848
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-5,030.648-5,026.08-2,843.02913,534.848
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-5,030.648-5,026.08-2,843.02913,534.848